Is erythritol safe for consumption in adults, and what adverse effects can occur with high intake?

Erythritol Safety: Current Evidence and Recommendations

Erythritol is generally recognized as safe by the FDA and American Diabetes Association for use as a sugar alcohol sweetener, but emerging cardiovascular risk data and established gastrointestinal tolerance limits warrant caution, particularly with high intake levels exceeding 0.5 g/kg body weight per day. 1, 2

Regulatory Status and Traditional Safety Profile

• The American Diabetes Association recognizes erythritol as an FDA-approved reduced-calorie sweetener (sugar alcohol/polyol) that produces lower postprandial glucose responses than sucrose or glucose, containing approximately 2 calories per gram. 1

• Erythritol is readily absorbed in humans, metabolized minimally to erythronate, and excreted unchanged in urine without genotoxicity concerns. 2

Gastrointestinal Tolerance Limits

The most well-established adverse effect is dose-dependent diarrhea, with a clear no observed adverse effect level (NOAEL) of 0.5 g/kg body weight per day. 2

• Single doses of 20-35 g erythritol in healthy adults are well-tolerated without significant gastrointestinal symptoms. 3

• At 50 g single doses, erythritol causes significant increases in nausea and borborygmi (intestinal rumbling), though it produces substantially fewer symptoms than equivalent xylitol doses. 3

• The European Food Safety Authority (EFSA) established an acceptable daily intake (ADI) of 0.5 g/kg body weight per day based on the diarrhea threshold, noting concerns about potential electrolyte and water imbalance with higher intakes. 2

• For a 70 kg adult, this translates to a maximum safe intake of approximately 35 g per day. 2

Emerging Cardiovascular Concerns

Recent high-quality observational studies from 2023-2025 reveal concerning associations between elevated circulating erythritol levels and cardiovascular outcomes, though causality remains unproven.

• A 2023 Nature Medicine study demonstrated that circulating erythritol levels in the highest quartile were associated with 1.80-2.21 times increased risk of major adverse cardiovascular events (death, myocardial infarction, or stroke) in stable cardiac patients. 4

• Physiological levels of erythritol enhanced platelet reactivity in vitro and thrombosis formation in vivo, with ingestion of 30 g erythritol producing sustained elevations (>2 days) above thresholds associated with heightened platelet reactivity. 4

• A 2025 JACC study in older adults (ARIC cohort) found that both erythritol and its metabolite erythronate were significantly associated with heart failure hospitalization, cardiovascular death, and total mortality after adjusting for traditional risk factors. 5

• A 2024 cohort study of 4,468 men showed elevated serum erythritol associated with 1.50-fold increased overall mortality risk, 1.86-fold increased cardiovascular disease mortality, and 1.54-fold increased cancer mortality over 19 years of follow-up. 6

Critical Caveats and Clinical Context

A crucial limitation is that these cardiovascular studies measured endogenous (body-produced) erythritol levels, not dietary intake, making direct causality with sweetener consumption uncertain. 5, 6, 4

• Erythritol is produced endogenously through the pentose phosphate pathway, and elevated levels may be markers of metabolic dysfunction rather than causative agents. 5

• Participants with higher erythritol levels had more diabetes, hypertension, obesity, and kidney disease—all confounding factors despite statistical adjustment. 5

• No long-term randomized controlled trials have assessed cardiovascular outcomes from dietary erythritol consumption specifically. 4

Practical Recommendations for Clinical Use

For adults without cardiovascular disease:

• Limit erythritol intake to below 0.5 g/kg body weight per day (approximately 35 g for a 70 kg adult) to avoid gastrointestinal effects. 2
• Single servings should remain below 35 g to minimize acute GI symptoms. 3

For adults with established cardiovascular disease, diabetes, or multiple risk factors:

• Exercise greater caution given the observational cardiovascular associations, though definitive dietary restrictions cannot be made based on current evidence. 5, 6, 4
• Consider alternative sweeteners until long-term safety data from dietary intake studies become available. 4

Common pitfall to avoid:

• Do not assume that "natural" or "sugar-free" products containing erythritol are risk-free, particularly when consumed in large quantities or multiple times daily. 2

Exposure Assessment Reality

• EFSA's 2023 assessment found that high-consuming children and adolescents may exceed the ADI, with 95th percentile chronic exposure reaching 742-1,532 mg/kg body weight per day. 2
• Acute exposure at the 99th percentile for children reached 3,531 mg/kg body weight per meal, though these estimates likely represent overestimations. 2